Recombinant Anti-EGFR × Anti-Fcgr1 Bispecific Antibody (CrossMab). This bsAb has been generated by applying the Crossmab format to generate an IgGshaped entity that binds each ligand with one arm. It was designed for the treatment of Head and neck cancer, colorectal cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.